Skip to content
Open access

Integrative multi-omics analysis identifies SLCO1B3 as a prognostic marker and functional oncogenic driver in head and neck squamous cell carcinoma

Oct 2026 · Translational Oncology · Vol 74 · 0 citations · 35 references
Medicine

TL;DR

Findings establish SLCO1B3 as an independent prognostic biomarker and functional driver that sustains stemness and malignant phenotypes in HNSCC, providing a rationale for its therapeutic targeting.

Abstract

Highlights • Elevated SLCO1B3 in HNSCC independently predicts worse survival.• Single-cell profiling links SLCO1B3 to an epithelial subset with enhanced stemness and progenitor traits.• Spatial transcriptomics shows SLCO1B3+ malignant epithelial cells preferentially colocalize with fibroblasts and SMCs.• Functional loss of SLCO1B3 attenuates malignant phenotypes of HNSCC cells.

Read PDF

Similar papers

Nov 2026

Integrated Single-Cell Transcriptomics Identifies Epi_C4 and Supports a Pro-Tumor Role for FAM20C in Lung Adenocarcinoma.

Intratumoral epithelial heterogeneity contributes to lung adenocarcinoma (LUAD) progression and may limit the interpretability of prognostic models derived from bulk tissue. To characterize this heterogeneity and assess its clinical relevance, four public single-cell RNA-sequencing datasets comprising 193,280 quality-c...

Xiao-Kui Sun, Hang-Bo Shen · 0 citations
Nov 2026

SLC9A3R1 Promotes Bladder Cancer Progression Through Regulation of Malignant Phenotypes: Integrated Bioinformatics Analysis and Experimental Validation.

SLC9A3R1 may promote bladder cancer progression through mTOR signaling and represents a potential prognostic biomarker and therapeutic target via differential expression, enrichment, and CIBERSORT analyses.

Yi-Ming Wang, Xiao-Xiang Wu, Chong Shu et al. · 0 citations
Sep 2026

SLC7A11 as a Prognostic Biomarker and Therapeutic Target in Renal Cell Carcinoma: Insights into Tumor Microenvironment Remodeling and Immune Infiltration.

INTRODUCTION SLC7A11 is part of the solute carrier family and encodes the transporter xCT. However, its functional role in renal cell carcinoma (RCC) progression and associated tumor microenvironment (TME) modulation remains poorly characterized and requires further investigation. This study aimed to explore SLC7A11 ex...

Xin-Yang Cheng, Jun Zhang, Ji-Xin Yuan et al. · 0 citations
Open access Oct 2026

Integrative multi-omics analysis identifies CCDC69 as a marker associated with germinal center B-cell infiltration in TNBC: development and validation

Although coiled-coil domain containing 69 (CCDC69) has been implicated in tumor biology, its role in triple-negative breast cancer (TNBC) and immune regulation remains unclear. Bulk transcriptomic data, single-cell RNA sequencing datasets, and spatial transcriptomics were used to investigate the role of CCDC69 in TNBC....

Jin-Jiao Li · 0 citations
Open access Oct 2026

Multi-omics bioinformatic screening identifies PFDN2 as an obesity-correlated molecular target of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is characterized by high malignancy, poor prognosis and a lack of specific therapeutic targets. Obesity acts as a major risk factor facilitating TNBC progression, while the molecular features underlying their correlation remain poorly systematically characterized. In this study, w...

Hui-Min Liu, Jun-Peng Huang, Qing-Yu Song · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.